SOL S.p.A. (SOL) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of SOL S.p.A. stock €24.59, price €63.20, that is 61.1% below the price, quality 54 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 2, 2026.
How to read this chart
60‑month range €14.39 – €63.40 · fair‑value band €12.53 – €34.45 · the €63.20 price screens above the €24.59 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 2, 2026.
Follow SOL S.p.A. in your weekly email
Every Wednesday you see whether SOL S.p.A. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
SOL S.p.A. produces and distributes technical and medical gases for industry and healthcare facilities in Italy and internationally.
Show moreShow less
The company supplies technical gases, equipment, systems, and services for the industrial sectors; and produces and distributes gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous helium, liquid helium, gases for electronics, ammonia, combustible gases for industrial use, and liquefied natural gas.
It also provides medical gases with AIC and medical devices, training services, electromedical equipment services, hospital hygiene and environmental monitoring, ambulance management, design and development of biobanks, and InfoHealth solutions; and respiratory and infusion therapies, healthcare and social care services, telemedicine and digital services, and healthcare aids.
In addition, the company offers CRYOLAB for transfer, storage and handling services of biological samples; DIATHEVA, which focuses on research, development, production, and marketing products, including monoclonal antibodies, recombinant proteins, and molecular kits for hospital research, diagnosis and clinical application, environmental, veterinary, and food; and PERSONAL GENOMICS for preventive and precision medicine.
SOL S.p.A. was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. operates as a subsidiary of Gas And Technologies World B.V.
Stock analysis
SOL S.p.A. (SOL) currently trades at €63.20, while our model-based Fair Value estimate is €24.59, 61% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of €29.37 per share, and 0 of the 26 models we run sit above the €63.20 price.
Bear case: the Dividend Discount group reads lowest at €5.28, and 26 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: €12.53 (bear) to €34.45 (bull), the price of €63.20 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
SOL S.p.A. reported revenue of €1.8B in FY2025 versus €1.1B in FY2021, a compound +12.4%/yr. Reported net income was €167M in FY2025, compounding +16.9%/yr from FY2021.
Key figures
Market cap €5.7B Mid · P/E ratio 33.1 · P/S ratio 3.06 · EPS (TTM) €1.91 · Dividend yield 0.7% · Net margin 9.2% · Return on equity 15.6% · Return on assets (EBIT) 10.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 58 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 40% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −41% fair-value upside, at −61%, SOL screens richer than that median.
Fair Value models
Bear€12.53Fair Value €24.59Bull€34.45
Price €63.20 · Downside -61.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (€1.24 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+10.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.8%
Start year 2020 (pandemic). Over 10 years: +10.2% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+14.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+13.3%
Dividend (yield on the price)0.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.13.3% vs 17.8%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.14% → 15%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+62.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+7.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +59.3% a year for the price and +5.1% for the forecasts.
AI conclusion: Recurring revenues from patient care provide a buffer against industrial cycles, yet scant public data limits visibility into durable competitive advantages.
Main risk: Scaling operations internationally tests operational discipline across technical gases and home care, which would hit execution efficiency and margins.
SOL Group delivers steady expansion through its technical gases for industry alongside growing home care services backed by acquisitions in new markets. The recurring revenues from patient care provide a buffer against industrial cycles, yet scaling operations internationally tests operational discipline. Does the defensive home care side ultimately deliver more predictable results than the gases activities?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 723 stocks
Beats the industry median on 5/14 measures
Overall it trails its industry peers.
Valuation
Quality Score54 · Above median
Fair Value upside−61.1% · Bottom 25%
Profitability
Return on equity (12 months)15.6% · Top 25%
Return on assets6.9% · Top 25%
Net margin (12 months)9.2% · Above median
Operating margin (12 months)15.5% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)9.4% · Below median
Dividend yield (12 months)0.7% · Below median
Balance sheet
Debt / equity0.45× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "SOL S.p.A. Fair Value". https://www.fairvalue-calculator.com/stock/SOL.MI
Frequently asked questions
Is SOL S.p.A. (SOL) overvalued or undervalued?
As of Nov 2, 2026, our model estimates a fair value of €24.59 versus a price of €63.20, about 61% lower (overvalued).
What is the fair value of SOL?
Our model-based fair value for SOL S.p.A. is €24.59 (as of Nov 2, 2026), built from audited fundamentals. The current price: €63.20.
What is the quality score of SOL?
SOL S.p.A. has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for SOL S.p.A. (SOL)?
Our model-based price target is the fair value of €24.59 (as of Nov 2, 2026) from 26 valuation models. Cautious scenario €12.53, optimistic scenario €34.45. It is a calculation from audited fundamentals, not an analyst target.
What is the SOL S.p.A. stock forecast for 2026?
Our models put fair value at €24.59, about 61% lower versus a price of €63.20 (overvalued). Cautious scenario €12.53, optimistic scenario €34.45. The calculation is refreshed regularly with new filings.
What is the revenue of SOL S.p.A. (SOL)?
SOL S.p.A. reported trailing-twelve-month revenue of about €1.9B (latest available figure, as of Nov 2, 2026).
Does SOL S.p.A. pay a dividend?
SOL S.p.A. currently shows a dividend yield of 0.71% relative to its recent price (as of Nov 2, 2026).
What growth is priced into SOL S.p.A. (SOL)?
For today's price to be fair in a discounted-cash-flow model, SOL S.p.A. would have to grow free cash flow by +62.8 % per year for five years (discount rate 10.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.8 % per year. As of Nov 2, 2026.
What discount rate (WACC) does the fair value of SOL use?
Our models discount SOL S.p.A. at 10.5 %: a base by market capitalisation (mid), damped by beta 0.41, country premium for Italy. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For SOL S.p.A. that is +62.8 % per year a year over ten years, using the same discount rate (10.5 %) and the same formula as our fair value.
How much growth has SOL S.p.A. (SOL) delivered so far?
Over the past 5 years revenue at SOL S.p.A. grew +12.8 % a year. The price currently implies +62.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of SOL S.p.A. (SOL) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into SOL S.p.A. (+62.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of SOL S.p.A. (SOL)?
The free-cash-flow yield on the price is 0.43 %: that much free cash flow SOL S.p.A. produces per unit of market value. When it exceeds the discount rate of our models (10.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of SOL S.p.A. (SOL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For SOL S.p.A. it is €24.59 per share (as of Nov 2, 2026), against a price of €63.20. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is SOL S.p.A. stock overvalued or undervalued in 2026?
As of Nov 2, 2026, SOL trades above its calculated fair value: price €63.20, fair value €24.59, a gap of about −61% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SOL?
No. The price is what the market pays today (€63.20); the fair value is what the company's own numbers justify (€24.59). For SOL S.p.A. the two are €38.61 per share apart. That gap is exactly why we show both numbers side by side.
How much is SOL S.p.A. worth?
The market values SOL S.p.A. at about €5.7B (market capitalisation, as of Nov 2, 2026). Per share that is €63.20; our models calculate a fair value of €24.59 per share.
What do the bullish and bearish scenarios say about SOL?
Our models span a range for SOL S.p.A.: cautious scenario €12.53, base €24.59, optimistic €34.45 per share (as of Nov 2, 2026, price €63.20). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SOL?
SOL S.p.A. trades at a price-to-earnings ratio of 33.1 (as of Nov 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €24.59 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 19.2. Other multiples: P/B 5.0, P/S 3.1, EV/EBITDA 13.9.
How solid is the balance sheet of SOL S.p.A. (SOL)?
Balance-sheet figures for SOL S.p.A. (as of Nov 2, 2026): return on equity 15.6%, debt of 0.45 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is SOL from its 52-week high?
SOL S.p.A. trades at €63.20, at its 52-week high of €63.40 and 40% above the low of €45.05 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of €24.59 is for.
Which stocks are comparable to SOL S.p.A.?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is SOL S.p.A. stock attractive at the current price?
The data as of Nov 2, 2026: price €63.20, calculated fair value €24.59 (−61%), Quality Score 54/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SOL calculated?
We run SOL S.p.A. through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €24.59, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. SOL S.p.A. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of SOL S.p.A. (SOL)?
The closing price on Nov 5, 2026 was €63.20. Our model-based fair value is €24.59, about 61% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with SOL S.p.A. right now?
The price sits above even our optimistic bull case (€34.45). The favourable scenario is already priced in. The model range is unusually wide (€12.53 to €34.45). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of SOL S.p.A. (SOL) come from?
Earnings per share at SOL S.p.A. grew +17.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +10.3 %, EBIT margin +3.2 %, tax rate +1.6 %, residual (interest, one-offs) +1.8 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of SOL S.p.A.
How large is the market capitalisation of SOL S.p.A. (SOL)?
The market capitalisation of SOL S.p.A. is €5.7B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of SOL S.p.A. (SOL)?
The price-to-sales ratio of SOL S.p.A. is 3.06 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of SOL S.p.A. (SOL)?
Earnings per share at SOL S.p.A. are €1.91 (price ÷ EPS = P/E 33.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of SOL S.p.A. (SOL)?
The dividend yield of SOL S.p.A. is 0.7% (payout 23.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of SOL S.p.A. (SOL)?
The net margin of SOL S.p.A. is 9.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of SOL S.p.A. (SOL)?
The return on equity (ROE) of SOL S.p.A. is 15.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of SOL S.p.A. (SOL)?
On an EBIT basis the return on assets of SOL S.p.A. is 10.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of SOL S.p.A. (SOL)?
The operating margin of SOL S.p.A. is 15.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at SOL S.p.A. (SOL)?
Revenue at SOL S.p.A. is growing +9.4% versus a year earlier (3y avg +8.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at SOL S.p.A. (SOL)?
Earnings per share at SOL S.p.A. are growing +8.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does SOL S.p.A. (SOL) carry?
The net debt of SOL S.p.A. is €488M (fiscal year 2025, ≈ 19.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch SOL S.p.A. in the live analysis
One click puts SOL S.p.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 2, 2026